Portfolio concentration
As of February 28, 2026 · N-PORT
Holdings
53
Top-10 weight
72.40%
Effective holdings
?
The number of equal-weight positions that would produce this portfolio's concentration (1 ÷ Herfindahl index). A 500-stock fund dominated by a few mega-caps might have only ~100 effective holdings.
11
Crowding
?
The value-weighted average number of funds that also own this fund's positions. High = consensus/crowded picks; low = holdings few other funds own.
1038.1
Holdings
As of February 28, 2026 · N-PORT| # | Security | Ticker | Shares | Value | % of fund |
|---|---|---|---|---|---|
| 1 | LILLY ELI and CO | — | 362,801 | $381.66M | 25.18% |
| 2 | GSK plc SPONSORED ADR | GSK US | 2,581,360 | $152.64M | 10.07% |
| 3 | JOHNSON&JOHNSON | — | 459,700 | $114.20M | 7.53% |
| 4 | UCB SA | — | 254,500 | $75.87M | 5.01% |
| 5 | ROCHE HOLDINGS AG (GENUSSCHEINE) | — | 157,090 | $74.76M | 4.93% |
| 6 | ASTRAZENECA PLC | — | 358,250 | $74.68M | 4.93% |
| 7 | GILEAD SCIENCES INC | — | 472,500 | $70.38M | 4.64% |
| 8 | MERCK & CO | — | 561,536 | $69.53M | 4.59% |
| 9 | ELANCO ANIMAL HEALTH INC | — | 2,536,200 | $66.96M | 4.42% |
| 10 | Fidelity Securities Lending Cash Central Fund | — | 64,528,911 | $64.54M | 4.26% |
| 11 | LEGEND BIOTECH CORP SPON ADR | — | 2,598,400 | $49.37M | 3.26% |
| 12 | JAZZ PHARMA PLC | — | 227,700 | $43.27M | 2.85% |
| 13 | MODERNA INC | — | 688,800 | $36.90M | 2.43% |
| 14 | ROYALTY PHARMA PLC | — | 750,500 | $34.68M | 2.29% |
| 15 | VIATRIS INC | — | 1,729,600 | $25.82M | 1.70% |
| 16 | FINANCIERE DE TU | — | 91,587 | $24.51M | 1.62% |
| 17 | BIONTECH SE ADR | — | 132,653 | $14.62M | 0.96% |
| 18 | MERCK Kommanditgesellschaft auf Aktien | MRK | 94,700 | $14.35M | 0.95% |
| 19 | BIOGEN INC | — | 73,000 | $14.00M | 0.92% |
| 20 | OCULAR THERAPEUTIX INC | — | 1,331,717 | $11.91M | 0.79% |
| 21 | BEAM THERAPEUTICS INC | — | 415,400 | $11.82M | 0.78% |
| 22 | XENON PHARMACEUTICALS INC | — | 268,600 | $11.61M | 0.77% |
| 23 | UNIQURE N.V. | — | 705,578 | $11.03M | 0.73% |
| 24 | CAPRICOR THERAPEUTICS INC | — | 389,900 | $10.89M | 0.72% |
| 25 | PTC THERAPEUTICS INC | — | 155,600 | $10.61M | 0.70% |
| 26 | KYMERA THERAPEUTICS INC | — | 102,000 | $9.32M | 0.61% |
| 27 | PHIBRO ANIMAL HEALTH CORP CL A | — | 150,755 | $8.23M | 0.54% |
| 28 | AXSOME THERAPEUTICS INC | — | 48,900 | $8.01M | 0.53% |
| 29 | ANNEXON INC | — | 1,264,100 | $7.08M | 0.47% |
| 30 | Ascendis Pharma A/S | — | 24,400 | $5.70M | 0.38% |
| 31 | CORCEPT THERAPEUTICS INC | — | 158,100 | $5.64M | 0.37% |
| 32 | AGOMAB THERAPEUTICS SA SER D PC PP | — | 332,858 | $5.33M | 0.35% |
| 33 | INTELLIA THERAPEUTICS INC | — | 384,500 | $5.30M | 0.35% |
| 34 | CRINETICS PHARMACEUTICALS INC | — | 122,800 | $5.05M | 0.33% |
| 35 | Fidelity Cash Central Fund | — | 4,809,384 | $4.81M | 0.32% |
| 36 | HARMONY BIOSCIENCES HOLDINGS INC | — | 158,577 | $4.53M | 0.30% |
| 37 | ARROWHEAD PHARMACEUTICALS INC | — | 65,400 | $4.14M | 0.27% |
| 38 | WAVE LIFE SCIENCES LTD | — | 296,800 | $4.13M | 0.27% |
| 39 | VERA THERAPEUTICS INC | — | 100,700 | $4.11M | 0.27% |
| 40 | AMYLYX PHARMACEUTICALS INC | — | 257,800 | $3.91M | 0.26% |
| 41 | DISC MEDICINE INC | — | 53,800 | $3.58M | 0.24% |
| 42 | DEFINIUM THERAPEUTICS INC | — | 188,000 | $3.28M | 0.22% |
| 43 | IDORSIA LTD | — | 639,660 | $3.26M | 0.21% |
| 44 | SUMMIT THERAPEUTICS INC | — | 169,304 | $2.81M | 0.19% |
| 45 | EDGEWISE THERAPEUTICS INC | — | 83,600 | $2.54M | 0.17% |
| 46 | ARRIVENT BIOPHARMA INC | — | 107,000 | $2.46M | 0.16% |
| 47 | VIKING THERAPEUTICS INC | — | 64,300 | $2.18M | 0.14% |
| 48 | PARAGON BIOSCIENCES EMALEX CAPITAL INC SER D-3 PC PP | — | 158,879 | $1.48M | 0.10% |
| 49 | CASTLE CREEK BIOSCIENCES INC SER D-2 PC PP | — | 6,308 | $1.42M | 0.09% |
| 50 | EVOZYNE INC SER B PC PP | — | 1,009,196 | $1.19M | 0.08% |
1 / 2
Next ›
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.